Alzheimer's Disease International (ADI)
Mario Possenti, CEO of ADI’s member Federazione Alzheimer Italia shares his gratitude to the Italian health workforce for their support of people living with dementia in the wake of the COVID-19 crisis.
Ahead of the G20 Health Ministers Meeting in Okayama, ADI’s Chief Executive Paola Barbarino and Noriyo Washizu of Alzheimer's Association Japan (AAJ) continue to work on progress made earlier in the year at the Osaka Summit.
On Young Carers Awareness Day, ADI Communications and Policy Manager, Annie Bliss, highlights some global examples of youth engagement in issues around dementia. Youth participation is critical for dementia communities globally, as young people play a huge role in volunteerism, advocacy and raising awareness.
This page has been set up in response to the crisis taking place in Ukraine. Here you can find an overview of resources and support for people who have been affected by the crisis, directly and indirectly. We will be adding to this page regularly.
In this blog from Orquidea Tamayo Mortera of Summerset, one of New Zealand’s leading independent retirement village operators, Orquidea writes about how Summerset is responding and rising to the evolving challenges of care for people living with dementia through innovative ways.
Launched on 23 January, the regional campaign aimed to put direct pressure on governments to implement National Dementia Plans.
ADI works to ensure that dementia is a global health priority by driving international policy efforts and supporting the national advocacy of member associations to get action from governments.
During these unprecedented times, ADI is bringing together news, resources, stories, advice and support for anyone affected by dementia around the world. This page and others are be dedicated to resources relating to the coronavirus disease (COVID-19) pandemic and will be updated on a regular basis.
The February 2021 issue of our Global Perspective newsletter.
The study by Institute for Health Metrics and Evaluation (IHME) published in The Lancet predicts 153 million people will be living with Alzheimer’s disease by 2050.